drugset / Trial / NCT04519788
AT-301 Nasal Spray in Healthy Adults
RandomizedSequentialQuadruple-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, ascending dose, multi-cohort study. The study will be conducted in 2 parts: a single ascending dose (SAD) part (Part 1) followed by a multiple ascending dose (MAD) part (Part 2).
Timeline
- Start
- 2020-08-07
- Primary completion
- 2020-12-08
- Completion
- 2021-01-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | AT-301B | Unknown | 0.2 ml | Intranasal |
| Comparator | AT-301B | Unknown | 0.4 ml | Intranasal |
Indications
No indication recorded.